ºñÁê¾ó
Publications

Research Papers

°Ô½ÃÆÇ º¸±â
ÀÛ¼ºÀÚ ÀÛ¼ºÀÚ°ü¸®ÀÚ
³¯Â¥ 2023-04-18 16:15:01
Á¦¸ñ An automatic analysis framework for FDOPA PET neuroimaging
±â»ç ¸µÅ© http://journals.sagepub.com/doi/epub/10.1177/0271678X231168687
An_automatic_analysis_framework_for_FDOPA_PET_neuroimaging.JPG

Abstract

In this study we evaluate the performance of a fully automated analytical framework for FDOPA PET neuroimaging data, and its sensitivity to demographic and experimental variables and processing parameters. An instance of XNAT imaging platform was used to store the King¡¯s College London institutional brain FDOPA PET imaging archive, alongside individual demographics and clinical information. By re-engineering the historical Matlab-based scripts for FDOPA PET analysis, a fully automated analysis pipeline for imaging processing and data quantification was implemented in Python and integrated in XNAT. The final data repository includes 892 FDOPA PET scans organized from 23 different studies. We found good reproducibility of the data analysis by the automated pipeline (in the striatum for the Kicer: for the controls ICC = 0.71, for the psychotic patients ICC = 0.88). From the demographic and experimental variables assessed, gender was found to most influence striatal dopamine synthesis capacity (F = 10.7, p < 0.001), with women showing greater dopamine synthesis capacity than men. Our automated analysis pipeline represents a valid resourse for standardised and robust quantification of dopamine synthesis capacity using FDOPA PET data. Combining information from different neuroimaging studies has allowed us to test it comprehensively and to validate its replicability and reproducibility performances on a large sample size.
Keywords
FDOPA PETdopamine synthesisdata analysis pipelineneuroimaging biomarkerbig data repository
÷ºÎÆÄÀÏ


ÃÑ °Ô½Ã¹° 54 ÆäÀÌÁö 1/4

   
°Ô½ÃÆÇ ¸®½ºÆ®
¹øÈ£ Á¦¸ñ ÆÄÀÏ ÀÛ¼ºÀÚ ³¯Â¥ Á¶È¸¼ö
54 Associations between post-traumatic stress diso... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.09.21 174
53 Different topological patterns in structural co... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.09.18 186
52 Medications for Psychosis: Dopamine Blockers an... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.09.15 115
51 Validation of the Korean Version of the Communi... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.07.28 107
50 Predictors of full recovery in patients with ea... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.07.28 201
49 Development of the Korea-Polyenvironmental Risk... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.07.12 52
48 The factor structure and clinical utility of cl... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.07.12 49
47 Three-year outcomes and predictors for full rec... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.07.12 36
46 Associations of Clozapine Use With Psychosocial... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.07.12 112
45 DNA Methylation Profiles of the DRD2 and NR3C1 ... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.07.12 34
44 Comparison of clinical features and 1-year outc... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.07.12 35
43 Clozapine Optimization: A Delphi Consensus Guid... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.07.12 79
ÇöÀç±Û An automatic analysis framework for FDOPA PET n... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2023.04.18 189
41 Modeling Approach with Therapeutic Drug Monitor... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2022.09.14 219
40 The Relationship Between Frontostriatal Connect... ÷ºÎÆÄÀÏ  °ü¸®ÀÚ 2022.07.25 224